Lenalidomide

Results: 231



#Item
101Immunosuppressants / Immunology / Bortezomib / Multiple myeloma / International Myeloma Foundation / Lenalidomide / Carfilzomib / Thalidomide / Proteasome inhibitor / Medicine / Cancer research / Cancer organizations

International Myeloma Foundation at Hard Rock Cafe

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2013-03-13 15:51:50
102Hematology / Plerixafor / Cancer research / Stem cells / Biotechnology / Multiple myeloma / Lenalidomide / Granulocyte colony-stimulating factor / International Myeloma Foundation / Medicine / Biology / Orphan drugs

MOZOBIL® Indications/ FDA Approval Mozobil (plerixafor injection) is approved by the United States Food and Drug Administration (FDA) to be used

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2012-04-18 11:53:09
103Immunosuppressants / Hematologic neoplasms / Lenalidomide / Multiple myeloma / Carfilzomib / Bortezomib / Dexamethasone / Thalidomide / Myelodysplastic syndrome / Medicine / Chemistry / Organic chemistry

International Myeloma Foundation ASH 2012 Multiple Myeloma Highlights

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2013-02-15 18:45:01
104Lenalidomide / Multiple myeloma / Celgene / Thalidomide / International Myeloma Working Group / Bortezomib / Carfilzomib / Dexamethasone / International Myeloma Foundation / Medicine / Immunosuppressants / Cancer research

IMF=logoV-whttag2011-cmyk.eps

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2014-04-04 17:44:05
105Multiple myeloma / Monoclonal gammopathy of undetermined significance / Plasmacytoma / Bence Jones protein / Lenalidomide / Hypercalcaemia / Plasma cell / Hyperviscosity syndrome / Osteoporosis / Medicine / Health / Hematologic neoplasms

Multiple Myeloma is a disease of the plasma cells in the bone marrow

Add to Reading List

Source URL: practicingclinicians.com

Language: English - Date: 2014-04-08 14:45:18
106Lymphocytic leukemia / Lymphoma / Plasma cell leukemia / Multiple myeloma / Stem cells / Monoclonal gammopathy of undetermined significance / Bortezomib / International Myeloma Working Group / Lenalidomide / Medicine / Oncology / Hematologic neoplasms

Plasma cell leukemia: consensus statement on diagnostic requirements, response criteria and treatment recommendations by the International Myeloma Working Group

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2013-10-30 13:23:23
107Immunosuppressants / Lenalidomide / Multiple myeloma / Thalidomide / Bortezomib / Hematopoietic stem cell transplantation / Carfilzomib / Dexamethasone / Methadone / Medicine / Chemistry / Organic chemistry

Understanding REVLIMID ®

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2013-01-07 08:57:33
108Hematopathology / Oncology / Lenalidomide / International Prognostic Scoring System / Myeloid leukemia / Iron overload / Hematopoietic stem cell transplantation / Chemotherapy / Anemia / Medicine / Myelodysplastic syndrome / Syndromes

What is MDS? (MDS Foundation, 2011) • MDS is a group of bone marrow disorders. The bone marrow is the factory for the production of blood cells including red blood cells, white blood cells, and platelets. In MDS, the

Add to Reading List

Source URL: www.mds-foundation.org

Language: English - Date: 2014-09-10 19:46:58
109Orphan drugs / Bendamustine / Benzimidazoles / Organochlorides / Rituximab / B-cell chronic lymphocytic leukemia / Lenalidomide / Genmab / Mantle cell lymphoma / Medicine / Oncology / Chemistry

JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON SELECTED PHARMACEUTICALS IN LATE STAGE U.S. AND E.U. DEVELOPMENT OR REGISTRATION as of[removed]Therapeutic Area Product Name

Add to Reading List

Source URL: files.shareholder.com

Language: English
110Healthcare reform in the United States / Presidency of Lyndon B. Johnson / Myelodysplastic syndrome / Syndromes / Erythropoietin / Medicare / Lenalidomide / Medicaid / National coverage determination / Medicine / Health / Federal assistance in the United States

2014: Volume 4, Number 4 A publication of the Centers for Medicare & Medicaid Services, Office of Information Products & Data Analytics Effect of Erythropoiesis-Stimulating Agent Policy Decisions on Off-Label Use in

Add to Reading List

Source URL: cms.gov

Language: English - Date: 2014-12-24 12:13:32
UPDATE